newsfilter
← Latest News
FDA Approved Drugs·

Approval of Opvee, Nda #217470 (Type 3 - New Dosage Form)

Approval Date: 05/22/2023; Drug Name: Opvee, Nda #217470; Active Ingredients: NALMEFENE; Company: Opiant Pharmaceuticals Inc; Submission Status: Approval; Submission Classification: Type 3 - New Dosage Form; Application Number: 217470

Company
OPIANT PHARMACEUTICALS INC
Keywords
OPIANT PHARMACEUTICALS INC